Concepedia

KE Caudle

KC

4

Publications

1.4K

Citations

4

H-Index

2015

Active since

Affiliations

St. Jude Children's Research Hospital(Current)

Stanford University

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Moffitt Cancer Center

KE Caudle is an author at St. Jude Children's Research Hospital specializing in clinical trials, drug discovery, and drug resistance.

Top concepts

Publications per year

2015–2016

4

Publications

4

Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update

JK Hicks, Katrin Sangkuhl, JJ Swen et al. · Clinical Pharmacology & Therapeutics · 2016 · 641 citations · Full text

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP2C19</i> and Voriconazole Therapy

Brad Moriyama, Aniwaa Owusu Obeng, Julia M. Barbarino et al. · Clinical Pharmacology & Therapeutics · 2016 · 379 citations · Full text

, , +14

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for<i>CYP2D6</i>genotype and use of ondansetron and tropisetron

GC Bell, KE Caudle, Michelle Whirl‐Carrillo et al. · Clinical Pharmacology & Therapeutics · 2016 · 205 citations · Full text

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update

Yoshiro Saito, L. Dudley Stamp, KE Caudle et al. · Clinical Pharmacology & Therapeutics · 2015 · 152 citations · Full text

Rows per page

1–4 of 4